Serum metabonomics study of chronic renal failure by ultra performance liquid chromatography coupled with Q-TOF mass spectrometry

被引:65
作者
Jia, Lewen [1 ,2 ]
Chen, Jing [1 ]
Yin, Peiyuan [1 ]
Lu, Xin [1 ]
Xu, Guowang [1 ]
机构
[1] Chinese Acad Sci, Dalian Inst Chem Phys, Natl Chromatog R&A Ctr, Dalian 116023, Peoples R China
[2] Dalian Univ Med, Affiliated Hosp 1, Dept Nephrol, Dalian 116011, Peoples R China
基金
中国国家自然科学基金;
关键词
metabonomics; UPLC; Q TOF MS; chronic renal failure; biomarker;
D O I
10.1007/s11306-008-0110-x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A metabonomics technique based on ultra-performance liquid chromatography (UPLC) coupled with Q-TOF mass spectrometry was employed to investigate the sera from 32 patients with chronic renal failure (CRF) without renal replacement therapy and 30 healthy volunteers in order to find potential disease biomarkers and reveal its pathophysiological changes. After data acquisition Waters MarkerLynx software was used to report retention time and m/z pairs for each metabolite peak, these data were exported to an excel table, then handled by using multivariate analysis and the statistical analysis in the SIMCA-P and the SPSS softwares to obtain potential biomarkers which were further identified by MS/MS. Seven potential biomarkers, creatinine, tryptophan, phenylalanine, kynurenine and three lysophosphatidylcholines, were identified. The results suggest that CRF can lead to the increase of reservation of creatinine in the body, and the abnormal metabolism of the two essential amino acids and lysophosphatidylcholines. It has indicated that metabonomics will be a powerful tool in the clinic research.
引用
收藏
页码:183 / 189
页数:7
相关论文
共 37 条
[1]   PLASMA AND MUSCLE FREE AMINO-ACIDS IN MAINTENANCE HEMODIALYSIS-PATIENTS WITHOUT PROTEIN-MALNUTRITION [J].
BERGSTROM, J ;
ALVESTRAND, A ;
FURST, P .
KIDNEY INTERNATIONAL, 1990, 38 (01) :108-114
[2]   Excerpts from the United States Renal Data System 2004 Annual Data Report: Atlas of end-stage renal disease in the United States - Perface [J].
Collins, AJ ;
Kasiske, B ;
Herzog, C ;
Chavers, B ;
Foley, R ;
Gilbertson, D ;
Grimm, R ;
Liu, JN ;
Louis, T ;
Manning, W ;
Matas, A ;
McBean, M ;
Murray, A ;
St Peter, W ;
Xue, J ;
Fan, Q ;
Guo, HF ;
Li, SL ;
Li, SY ;
Roberts, T ;
Snyder, J ;
Solid, C ;
Wang, CC ;
Weinhandl, E ;
Arko, C ;
Chen, SC ;
Dalleska, F ;
Daniels, F ;
Dunning, S ;
Ebben, J ;
Frazier, E ;
Johnson, R ;
Sheets, D ;
Forrest, B ;
Berrini, D ;
Constantini, E ;
Everson, S ;
Frederick, P ;
Eggers, P ;
Agodoa, L .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2005, 45 (01) :V-+
[3]   Application of nuclear magnetic resonance spectroscopy combined with principal component analysis in detecting inborn errors of metabolism using blood spots: a metabonomic approach [J].
Constantinou, MA ;
Papakonstantinou, E ;
Benaki, D ;
Spraul, M ;
Shulpis, K ;
Koupparis, MA ;
Mikros, E .
ANALYTICA CHIMICA ACTA, 2004, 511 (02) :303-312
[4]   Chronic kidney disease awareness, prevalence, and trends among US adults, 1999 to 2000 [J].
Coresh, J ;
Byrd-Holt, D ;
Astor, BC ;
Briggs, JP ;
Eggers, PW ;
Lacher, DA ;
Hostetter, TH .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2005, 16 (01) :180-188
[5]   Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey [J].
Coresh, J ;
Astor, BC ;
Greene, T ;
Eknoyan, G ;
Levey, AS .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2003, 41 (01) :1-12
[6]   Serum metabolomics reveals many novel metabolic markers of heart failure, including pseudouridine and 2-oxoglutarate [J].
Dunn, Warwick B. ;
Broadhurst, David I. ;
Deepak, Sasalu M. ;
Buch, Mamta H. ;
McDowell, Garry ;
Spasic, Irena ;
Ellis, David I. ;
Brooks, Nicholas ;
Kell, Douglas B. ;
Neyses, Ludwig .
METABOLOMICS, 2007, 3 (04) :413-426
[7]  
Duong CQ, 2004, BBA-MOL CELL BIOL L, V1682, P112
[8]  
EGGERS PW, 1999, KIDNEY FAILURE FEDER
[9]   Clinical biomarkers in drug discovery and development [J].
Frank, R ;
Hargreaves, R .
NATURE REVIEWS DRUG DISCOVERY, 2003, 2 (07) :566-580
[10]   Levels of cholesteryl esters and other lipids in the plasma of patients with end-stage renal failure [J].
Gillett, MPT ;
Obineche, EN ;
Lakhani, MS ;
Abdulle, AM ;
Amirlak, I ;
Al Rukhaimi, M ;
Suleiman, MN .
ANNALS OF SAUDI MEDICINE, 2001, 21 (5-6) :283-286